If Company A, a Medical Research Company, Makes a New

Multiple Choice

If company A, a medical research company, makes a new product discovery and their stock rises 5%, this will have:

A) no effect on Company B's, a newspaper, stock price because it is a systematic risk element.
B) no effect on Company B's, a newspaper, stock price because it is an unsystematic risk element.
C) a large effect on Company B's, a newspaper, stock price because it is a systematic risk element.
D) a large effect on Company B's, a newspaper, stock price because it is an unsystematic risk element.
E) None of the above.